Bristol Myers Squibb Gains FDA Nod for Injectable Opdivo
Bristol Myers Squibb secures FDA approval for injectable Opdivo, potentially reshaping the healthcare sector. Discover its impact on pharmaceuticals.
Bristol Myers Squibb received FDA approval for an injectable form of Opdivo, which may impact the healthcare sector.